Boston Scientific (BSX) EBITDA Margin (2009 - 2026)
Boston Scientific's (BSX) quarterly EBITDA Margin came in at 21.65% in Q2 2026, up 546.0% year-over-year from 3.35% in Q2 2025, and up 2.29% quarter-over-quarter from 21.16% in Q1 2026.
Powered by 
Analysis
Boston Scientific (BSX) EBITDA Margin (2009 - 2026) Analysis & Trends
Boston Scientific has disclosed EBITDA Margin across 18 years of filings, most recently posting 21.65% for Q2 2026.
- In Q2 2026, EBITDA Margin rose 546.0% year-over-year to 21.65%; the TTM figure through Jun 2026 stood at 19.78% (up 275.0% YoY), while the FY2025 annual figure was 18.0%, up 246.0% from the prior year.
- EBITDA Margin came in at 21.65% for Q2 2026 at Boston Scientific, up from 21.16% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 21.65% in Q2 2026 to a low of 11.29% in Q3 2022.
- Average EBITDA Margin over 5 years is 16.41%, with a median of 15.93% recorded in 2025.
- Year-over-year, EBITDA Margin soared 836 bps in 2023 and sank 223 bps in 2024.
- Over 5 years, EBITDA Margin stood at 12.4% in 2022, then grew by 26 bps to 15.68% in 2023, then dropped by 6 bps to 14.8% in 2024, then advanced by 5 bps to 15.61% in 2025, then soared by 39 bps to 21.65% in 2026.
- Per Business Quant data, the three most recent EBITDA Margin figures were 21.65% in Q2 2026, 21.16% in Q1 2026, and 15.61% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 19.15% |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 14.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.65% |
| Mar 31, 2026 | 21.16% |
| Dec 31, 2025 | 15.61% |
| Sep 30, 2025 | 20.69% |
| Jun 30, 2025 | 16.18% |
| Mar 31, 2025 | 19.75% |
| Dec 31, 2024 | 14.80% |
| Sep 30, 2024 | 17.42% |
| Jun 30, 2024 | 12.62% |
| Mar 31, 2024 | 17.51% |
| Dec 31, 2023 | 15.68% |
| Sep 30, 2023 | 19.65% |
| Jun 30, 2023 | 14.28% |
| Mar 31, 2023 | 16.29% |
| Dec 31, 2022 | 12.40% |
| Sep 30, 2022 | 11.29% |
| Jun 30, 2022 | 13.04% |
| Mar 31, 2022 | 15.40% |
| Dec 31, 2021 | 5.76% |
| Sep 30, 2021 | 13.20% |